Novartis AGNVSNYSE
Loading
Year-over-year net income growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-4.7x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -38.68% |
| Q3 2025 | -2.80% |
| Q2 2025 | 12.06% |
| Q1 2025 | 27.96% |
| Q4 2024 | -11.63% |
| Q3 2024 | -1.76% |
| Q2 2024 | 20.76% |
| Q1 2024 | -68.30% |
| Q4 2023 | 381.54% |
| Q3 2023 | -23.96% |
| Q2 2023 | 1.00% |
| Q1 2023 | 56.41% |
| Q4 2022 | -6.80% |
| Q3 2022 | -7.14% |
| Q2 2022 | -23.76% |
| Q1 2022 | -86.37% |
| Q4 2021 | 491.30% |
| Q3 2021 | -4.77% |
| Q2 2021 | 40.65% |
| Q1 2021 | -1.67% |
| Q4 2020 | 8.22% |
| Q3 2020 | 3.64% |
| Q2 2020 | -14.20% |
| Q1 2020 | 93.42% |
| Q4 2019 | -44.91% |
| Q3 2019 | -69.97% |
| Q2 2019 | 284.99% |
| Q1 2019 | 47.78% |
| Q4 2018 | -26.37% |
| Q3 2018 | -79.11% |
| Q2 2018 | 283.60% |
| Q1 2018 | 2.48% |
| Q4 2017 | -5.05% |
| Q3 2017 | 5.10% |
| Q2 2017 | 18.85% |
| Q1 2017 | 74.09% |
| Q4 2016 | -50.67% |
| Q3 2016 | 7.54% |
| Q2 2016 | -10.29% |
| Q1 2016 | 90.80% |